Indian businesses are preparing for the possible impact of new 50% US tariffs.

Exporters are assessing whether they can pass costs onto customers or absorb losses.

IT services companies see limited direct effect but are cautious about currency volatility.

Pharma exporters are closely tracking US price movements and regulatory shifts.

Engineering exporters may face short-term order delays due to rising input costs.

Specialty chemical makers are exploring alternate overseas markets for growth.

Policy makers may consider logistical and financial support for stressed sectors.

Brokerages suggest selective exposure to export-oriented companies.

Domestic consumption-driven sectors may see relative investor preference.

The trade negotiations calendar will remain a key driver of sentiment.